knowledge -WSS

knowledge

author：hotspot 2025-09-02 05:44:01 - browse：99

A crowd of miniature figurines facing towards an hourglass. -- cancer coverage from STAT — Adobe

It’s no secret that a lucky few seem to glide into old age, the years settling gracefully on their bodies, while others appear to have been dragged through time tied to a metaphorical garbage truck. Biologists have been developing numerous ways to measure the rate an individual ages — often called an accelerated or decelerated “biological age” — and trying to translate it into a heightened or reduced risk of the morbidity and mortality that comes with aging.

There’s been a proliferation of various biological aging clocks, mathematical models that look at things like genetic markers or proteins in your body to make some estimation of an individual’s biological age. Research interest in using these clocks has exploded. In the last five years, thousands of papers on or incorporating the clocks have been published. The paper describing one popular biological aging clock, PhenoAge, has over 1,800 citations alone. One recent study suggested that a reason cancer incidence is increasing among younger adults may be accelerated aging, based on this particular clock.

But as scientists use these clocks to associate biological age with specific health risks, like cancer or dementia, and numerous companies eagerly offer biological age measurements in exchange for hundreds of bucks, it may be worth noting that experts don’t agree on what “biological age” actually is.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Bright Health sells Medicare Advantage business to Molina
Next article： Apellis safety probe of eye disease drug centers on injection needle

knowledge

WSS

Study finds new variant for Parkinson’s in African populations

How to make Best Hospitals ratings actually useful for patients

How a symptom of dementia informs our understanding of creativity

NYU Langone launches private ChatGPT for its health care data

For Cytokinetics, FDA rejection of heart drug would help, not hinder

In science, is the line between industry and academia shifting?

entertainment

knowledge

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

knowledge

23andMe had bad news about my health. I wish a person had delivered it

Winners, losers from Medicare’s list of drugs subject to price talks

Trump demands the U.S. pay no more for drugs than other countries … again

Emergent cuts jobs, executive role in business shake

United colonoscopy coverage change 'may cost lives,' doctors say

Police still searching for prisoner who escaped from NYC hospital

Alkermes shareholders re

How a symptom of dementia informs our understanding of creativity

Supreme Court strikes down use of affirmative action

The best solution to the drug shortages problem

explore

2024 GOP presidential candidates spar over abortion in debate

Apellis safety probe of eye disease drug centers on injection needle

Study finds new variant for Parkinson’s in African populations

Psilocybin's anti

Man killed during FBI raid in connection with threats against Biden, other officials

In science, is the line between industry and academia shifting?

focus

knowledge

knowledge

explore